If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
227.50    2.50 (1.11%)
Bid:
225.00
Ask:
230.00
Spread: 5.00 (2.222%)
Market Cap: £110.24m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

Today 07:00

RNS Number : 3938L
Quartix Technologies PLC
08 July 2026
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, software and services, is pleased to report that it will publish interim results for the six-month period ending 30 June 2026 (the "Period") on Monday 27 July 2026. They will be posted on the Company's website that morning, together with an accompanying presentation.

Estimated Financial Results for the Period

Management estimates that the financial results for the Period will be as follows:

· Revenue: £19.4m (**restated H1 2025: £17.3m)

· EBITDA £6.9m (restated H1 2025: £6.2m)

· Adjusted EBIT £4.6m (restated H1 2025: £4.0m)

· Free cashflow: £2.6m (H1 2025: £2.5m).

· Closing cash balance of £4.7m (H1 2025: £4.1m)

 

Notes:

These figures may be subject to revision following completion of management accounts for June and preparation of the interim results.

**Included within the Annual Report for 2025, which can be accessed on the Company website, is an explanation for the change in accounting policy that was processed in the 2025 financial statements.

The estimated free cashflow is stated after accounting for a £1.1m corporation tax payment in relation to the Group's change in accounting policy on property, plant and equipment (IAS 16) at the end of 2025 and the Company anticipates making an additional payment of approximately £400k in July following the refiling of the 2024 tax return.

Annualised Recurring Revenue ("ARR")

ARR is the key forward-looking measure of growth for the Company and an important indicator of shareholder value. ARR reported by the Company relates solely to committed software subscription revenues and does not include other service revenues which may recur.

On a trailing-twelve-month ("TTM") basis to 30 June 2026 the Company's ARR has grown by £3.8m, or 11% (30 June 2025: £4.1m TTM) reflecting continued double-digit growth. £2.1m of this growth was achieved during the Period.

Net revenue retention ("NRR") on a TTM basis marginally decreased from 97.3% in June 2025 to 96.9% at the end of the Period. The reduction in NRR was primarily attributable to the UK which had delivered 100% NRR in the 12 months to 30 June 2025. Improvement in this measure is targeted across all territories.

Measures of ARR and ARR growth are calculated on a constant-currency basis2.

Customer acquisition

On a TTM basis the customer base grew by 6% to 33,550 and the total subscription base increased by 7% to 342,679, demonstrating the resilience and quality of the Group's recurring revenue model.

Although the number of new customers acquired and new subscriptions installed in the Period were weaker than in the same period last year, (decreasing by 8% to 3,632 and by 11% to 36,226, respectively), the Company has a good order backlog for installation in the second half.

The key metrics for the Group are shown below:

 

Country

 ARR Growth in Period (£m)

ARR (£m)

TTM Growth

New Subscriptions (units)

Subscription Base (units)

TTM Growth

New Customers

Customer Base

TTM Growth

UK/EI

0.7

20.4

7%

12,248

167,891

2%

832

12,019

1%

France

0.8

10.6

14%

12,015

96,770

11%

1,169

10,101

6%

USA

0

3.4

1%

2,990

29,025

(3%)

402

3,883

(3%)

Italy

0.3

2.2

39%

4,701

23,408

38%

620

3,560

33%

Spain

0.2

1.4

31%

2,831

16,638

27%

417

2,704

15%

Germany

0.1

0.9

20%

1,409

8,586

14%

188

1,224

14%

Other

-

-

(21%)

32

361

(24%)

4

59

(17%)

Total

2.1

38.9

11%

36,226

342,679

7%

3,632

33,550

6%

 

Outlook

The Company is confident of achieving market expectations1 for the year for revenue, Adjusted EBIT and free cashflow and expects to declare an interim dividend of 2.7p per ordinary share (2025: 2.5p).

Andy Walters, Executive Chairman of Quartix, commented:

" We have made solid progress in the first half of 2026. Over the past 12 months, annualised subscription revenue has increased by £3.8m, or 11%, to £38.9m, representing continued double-digit growth. We enter the second half of the year with a strong order book for installation and expect improved performance in H2. The Board is confident of delivering results for the full year in line with market expectations."

 Notes:

1 The Company believes that market expectations for 2026 were, prior to this announcement, revenue £40.3m, adjusted EBIT £10.1m, EBITDA of £15.0m, and free cashflow of £4.9m.

2 Comparisons made on the basis of constant-currency measurements are based on closing exchange rates applicable at 30/6/2026 of $1.3221 and €1.1604 to pounds sterling.

For further Information please contact:

Quartix (www.quartix.com)

Andrew Walters, Executive Chairman

Sally Morton, Company Secretary & Financial Director

 

01686 806 663

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Trisyia Jamaludin (Corporate Finance)

Sunila de Silva (Equity Capital Markets)

020 7200 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGGNVNDGVZM
Date   Source Headline
8th Jul 20267:00 amRNSTrading Statement
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.